ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 28 filers reported holding ASLAN PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,747,000 | -20.8% | 1,941,219 | -1.5% | 0.03% | 0.0% |
| Q4 2021 | $2,206,000 | -37.1% | 1,970,000 | 0.0% | 0.03% | -28.2% |
| Q3 2021 | $3,507,000 | -57.8% | 1,970,000 | -21.8% | 0.04% | -53.6% |
| Q2 2021 | $8,316,000 | -1.5% | 2,520,000 | 0.0% | 0.08% | +6.3% |
| Q1 2021 | $8,442,000 | – | 2,520,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,270,758 | $2,262,000 | 0.72% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $4,476,000 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 975,305 | $1,736,000 | 0.36% |
| DAFNA Capital Management LLC | 732,500 | $1,304,000 | 0.35% |
| KNOTT DAVID M | 478,186 | $851,000 | 0.31% |
| Vivo Capital, LLC | 2,840,909 | $5,057,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 688,400 | $1,225,000 | 0.17% |
| MYDA Advisors LLC | 236,165 | $420,000 | 0.12% |
| Affinity Asset Advisors, LLC | 250,000 | $445,000 | 0.11% |
| RTW INVESTMENTS, LP | 3,250,000 | $5,785,000 | 0.09% |